Axogen
Supplies nerve grafts and protective implants for surgical peripheral nerve repair.
$52.49
After-hours close+0.98 (+1.90%)
At close$51.51(−0.43%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 103.60%Insiders 1.71%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 53.76M · Float 52.20M · 97.1% free float
Institutions13F, as of Jun 30, 2026
259 holders · 55.70M shares · 57 new positions · 165 increased · 66 reduced · 22 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 4.42M | 8.22% | +548.4K | Aug 7, 2026 |
| First Light Asset Management, LLC | 2.75M | 5.11% | −1.25M | Aug 14, 2026 |
| Morgan Stanley | 2.75M | 5.11% | −375.1K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 2.26M | 4.20% | −33.6K | Aug 13, 2026 |
| Polar Capital Holdings PLC | 1.50M | 2.79% | 0 | Aug 14, 2026 |
| Artemis Investment Management LLP | 1.40M | 2.60% | +1.05M | Jul 23, 2026 |
| Wellington Management Group LLP | 1.39M | 2.59% | +427.1K | Aug 14, 2026 |
| Geode Capital Management, LLC | 1.38M | 2.56% | +155.1K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| First Light Asset Management, LLC | 6.19% | 3.29M | 13G | May 7, 2026 ↗ |
| Morgan Stanley | 5.30% | 2.33M | 13G | Feb 3, 2025 ↗ |
| Vanguard Capital Management | 5.12% | 2.66M | 13G | Apr 29, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Erick Wayne DeVinney | officer: Chief Innovation Officer | 256.4K | 0.48% | Mar 18, 2026 |
| Amy McBride Wendell | director | 108.0K | 0.20% | Aug 12, 2026 |
| Doris Quackenbush | officer: Sales VP | 92.4K | 0.17% | May 8, 2026 |
| Guido J. Neels | director | 86.7K | 0.16% | Jun 11, 2025 |
| Jens Kemp | officer: Chief Marketing Officer | 72.5K | 0.13% | May 8, 2026 |
| Michael D. Dale | officer: Chief Executive Officer | 63.5K | 0.12% | Dec 12, 2025 |
| Lindsey Marie Hartley | officer: CFO | 62.8K | 0.12% | May 8, 2026 |
| Alan M. Levine | director | 50.9K | 0.09% | Jun 23, 2026 |
| Marc A. Began | officer: EVP & General Counsel | 50.1K | 0.09% | Aug 12, 2026 |
| Paul Thomas | director | 32.4K | 0.06% | Jun 23, 2026 |
4 ten-percent owners hold 8.56M shares by Form 4, outside the officers-and-directors figure above · 29 people have not refiled in the last 18 months (4.35M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 11, 2026 | Amy McBride Wendelldirector | Sale | 13,353 | $48.42 | 107,976 |
| Aug 10, 2026 | Marc A. Beganofficer: EVP & General Counsel | Sale | 67,500 | $47.35 | 50,135 |
| Aug 7, 2026 | Kathy Johnson Weilerdirector | Sale | 14,150 | $45.30 | 0 |
| May 8, 2026 | Amy McBride Wendelldirector | Sale | 1,647 | $42.60 | 93,826 |
| May 7, 2026 | Doris Quackenbushofficer: Sales VP | Sale | 3,878 | $43.51 | 92,416 |
| May 7, 2026 | Lindsey Marie Hartleyofficer: CFO | Sale · 2 lots | 1,051 | $43.67 | 62,756 |
| May 7, 2026 | Jens Kempofficer: Chief Marketing Officer | Sale | 4,000 | $43.44 | 72,451 |
| May 7, 2026 | Kathy Johnson Weilerdirector | Sale | 16,344 | $44.09 | 0 |
| May 7, 2026 | John Johnsondirector | Sale | 11,050 | $43.26 | 0 |
| Mar 16, 2026 | Erick Wayne DeVinneyofficer: Chief Innovation Officer | Sale | 5,221 | $32.84 | 262,781 |
CongressHouse and Senate disclosures
Not reported.